New analysis of trial of semaglutide in adolescents shows it can reduce liver enzymes indicative of liver damage
A new substudy of the STEP TEENS trial presented at this year’s European Congress on Obesity (ECO 2023, Dublin 17-20 May) shows that adolescents using semaglutide experienced significant… read more.
